Page last updated: 2024-10-17

4-aminoimidazole and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

4-aminoimidazole has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

4-aminoimidazole: structure in first source
4-aminoimidazole : An aminoimidazole that is 1H-imidazole substituted by an amino group at position 4.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
"To study the effect of 5-aminoimidazole-4-formamide ribonucleotide (AICAR) combined with interferon (IFN-α-2b) on the proliferation and apoptosis of chronic myeloid leukemia K562 cells, and explore its possible mechanism."1.56[Effect of 5-aminoimidazole-4-formamide Ribonucleotide Combined with Interferon on Chronic Myeloid Leukemia K562 Cells]. ( Ge, FM; Liu, R; Wang, HJ; Zhang, YY, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, HJ1
Liu, R1
Zhang, YY1
Ge, FM1

Other Studies

1 other study available for 4-aminoimidazole and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
[Effect of 5-aminoimidazole-4-formamide Ribonucleotide Combined with Interferon on Chronic Myeloid Leukemia K562 Cells].
    Zhongguo shi yan xue ye xue za zhi, 2020, Volume: 28, Issue:6

    Topics: Apoptosis; Cell Proliferation; Formamides; Humans; Imidazoles; Interferons; K562 Cells; Leukemia, My

2020